Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8963760 | The Journal of Allergy and Clinical Immunology: In Practice | 2018 | 9 Pages |
Abstract
Previous exposure to oxaliplatin is a risk factor for earlier HSR onset and more severe and frequent HSR episodes, even if prior therapy was well tolerated.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kyoung-Hee MD, Dong-Yoon MD, Ju-Young MD, Suh-Young MD, Kyung-Hun MD, PhD, Sae-Won MD, PhD, Hye-Ryun MD, PhD,